HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting opioid receptors: A new treatment for brain disorders.

AuthorsShafiqur Rahman
JournalCNS & neurological disorders drug targets (CNS Neurol Disord Drug Targets) Vol. 9 Issue 2 Pg. 128 (Apr 2010) ISSN: 1996-3181 [Electronic] United Arab Emirates
PMID20401980 (Publication Type: Editorial)
Chemical References
  • Antidepressive Agents
  • Narcotic Antagonists
  • Receptors, Opioid, kappa
  • norbinaltorphimine
  • Naltrexone
Topics
  • Animals
  • Antidepressive Agents (pharmacology, therapeutic use)
  • Anxiety Disorders (drug therapy, metabolism, physiopathology)
  • Brain (drug effects, metabolism, physiopathology)
  • Depressive Disorder (drug therapy, metabolism, physiopathology)
  • Disease Models, Animal
  • Humans
  • Limbic System (drug effects, metabolism, physiopathology)
  • Naltrexone (analogs & derivatives, pharmacology, therapeutic use)
  • Narcotic Antagonists (pharmacology, therapeutic use)
  • Rats
  • Rats, Inbred WKY (physiology, psychology)
  • Receptors, Opioid, kappa (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: